| Stephen T Mcdavid, DO | |
|
3109 Bienville Blvd, Ocean Springs, MS 39564-4361 | |
| (228) 818-1158 | |
| (228) 762-3147 |
| Full Name | Stephen T Mcdavid |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 3109 Bienville Blvd, Ocean Springs, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013958644 | NPI | - | NPPES |
| 000125627 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 17316 (Mississippi) | Secondary |
| 2083P0011X | Preventive Medicine - Undersea And Hyperbaric Medicine | 17316 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Singing River Health System | Pascagoula, MS | Hospital |
| Garden Park Medical Center | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singing River Health System | 3870405194 | 156 |
| Singing River Gulfport | 5294154829 | 106 |
News Archive
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
The Center for Reproductive Rights has released its online World's Abortion Laws map for 2011. The center has produced the map since 1998 "to visually compare the legal status of induced abortion in different countries - and to advocate for greater progress in ensuring access to safe and legal abortion services for all women worldwide."
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.
› Verified 8 days ago
| Entity Name | Singing River Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
The Center for Reproductive Rights has released its online World's Abortion Laws map for 2011. The center has produced the map since 1998 "to visually compare the legal status of induced abortion in different countries - and to advocate for greater progress in ensuring access to safe and legal abortion services for all women worldwide."
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.
› Verified 8 days ago
| Entity Name | South Mississippi Surgeons |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598776627 PECOS PAC ID: 9032198155 Enrollment ID: O20040714000349 |
News Archive
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
The Center for Reproductive Rights has released its online World's Abortion Laws map for 2011. The center has produced the map since 1998 "to visually compare the legal status of induced abortion in different countries - and to advocate for greater progress in ensuring access to safe and legal abortion services for all women worldwide."
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.
› Verified 8 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
The Center for Reproductive Rights has released its online World's Abortion Laws map for 2011. The center has produced the map since 1998 "to visually compare the legal status of induced abortion in different countries - and to advocate for greater progress in ensuring access to safe and legal abortion services for all women worldwide."
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen T Mcdavid, DO 2101 Highway 90, Gautier, MS 39553-5340 Ph: (228) 497-7576 | Stephen T Mcdavid, DO 3109 Bienville Blvd, Ocean Springs, MS 39564-4361 Ph: (228) 818-1158 |
News Archive
After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."
UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.
Dyadic International, Inc. a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,794,962 by the United States Patent and Trademark Office.
The Center for Reproductive Rights has released its online World's Abortion Laws map for 2011. The center has produced the map since 1998 "to visually compare the legal status of induced abortion in different countries - and to advocate for greater progress in ensuring access to safe and legal abortion services for all women worldwide."
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.
› Verified 8 days ago